An inhibitor of oxidative phosphorylation exploits cancer vulnerability

Authors: Jennifer R. Molina, Yuting Sun, Marina Protopopova, Sonal Gera, Madhavi Bandi, Christopher A. Bristow, Timothy McAfoos, Pietro Morlacchi, Jeffrey J. Ackroyd, Ahmed-Noor A. Agip, Gheath Alatrash, John M. Asara, Jennifer Bardenhagen, Caroline C. Carrillo, Christopher L. Carroll, Edward Chang, Stefan O. Ciurea, Jason B. Cross, Barbara Czakó, Angela K. Deem, Naval Daver, John Frederick De Groot, Jian-Wen Dong, Ningping Feng, Guang Gao, Jason Gay, Mary Geck, Jennifer Greer, Virginia Giuliani, Jing Han, Lina Han, Verlene Henry, Judy Hirst, Sha Huang, Yongying Jiang, Zhijun Kang, Tin Oo Khor, Sergej Konoplev, Yu-Hsi Lin, Gang Liu, Alessia Lodi, Timothy Lofton, Helen Ma, Mikhila Mahendra, Polina Matre, Robert A. Mullinax, Michael Peoples, Alessia Petrocchi, Jaime Rodriguez-Canale, Riccardo Serreli, Thomas Shi, Melinda Smith, Yoko Tabe, Jay Theroff, Stefano Tiziani, Quanyun A. Xu, Qi Zhang, Florian L. Müller, Ronald A. DePinho, Carlo Toniatti, Giulio Draetta, Timothy P. Heffernan, Marina Konopleva, Philip Jones, Maria Emilia Di Francesco, Joseph R. Marszalek - Nature Medicine 2018 cited by 951